Thursday, 18 Oct 2018

You are here

Practice Patterns of PJP Prophylaxis Among ID Physicians

While the incidence of pneumocystis pneumonia (PJP) is low is patients with rheumatologic diseases the mortality is quite high compared to PJP in patients with HIV and infection can be prevented with appropriate prophylaxis. In HIV prophylaxis is guided by CD4 counts but in the rheumatology world we have nothing to guide us and there exist no formal recommendations as far as when to start/stop PJP prophylaxis.


Rachel M Wolfe and her group queried infectious disease physicians using an electronic survey e-mailed out to 1,264 members of the Infectious Disease Society of America to assess practice patterns for PJP prophylaxis in patients with rheumatologic diseases. They had a response rate of 50% (631 physicians) and nearly half answered that they did not make recommendations for PJP prophylaxis in non-HIV patients. Of the remaining responders, it is not at all surprising that there was very little agreement regarding what they felt to be indications for PJP prophylaxis. The most common agreed upon indication was GPA (53%) but only one third recommended prophylaxis for other types of vasculitis, SLE, inflammatory myositis and RA with high dose glucocorticoids. The response “not sure” was selected by 35%.

In terms of specific therapies, 87% would recommend prophylaxis for patients receiving prednisone ≥20mg/day. Only 21% used surrogate biomarkers to guide this decision, with CD4 count alone being the most frequent.   

 

I do feel that if rheumatologists were sent this survey the responses would have been just as varied, and this abstract highlights the great need for standardized PJP prophylaxis guidelines.

 

Add new comment

More Like This

RheumNow Week in Review – Four Fingers are Best (10.12.18)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. New info on scleroderma-SLE overlap, nailfold capillaroscopy, Women with SpA, acute gout management and lupus patient in pain who visit the ED.

RheumNow Week in Review – Vitamin D Falls Again (10.4.18)

Dr. Jack Cush reviews the news from the past week on RheumNow.com. 

RheumNow Week in Review – I Wanna New Drug (9.28.18)

Dr. Jack Cush reviews the news from the past week on RheumNow.com, including news on inappropriate opioids, pre-clinical RA treatment, DMARDs in Gout, the decline of arthroscopy, and a pain in the mouth.

CDC: 2017 Record Number of Influenza Deaths

The CDC reports that in 2017, influenza killed and hospitalized more people in the United States than any other year in the last few decades. (Citation Source http://bit.ly/2DBr0TE)

RheumNow Week in Review – RheumNow Live Meeting Announcement (9.21.18)

Dr. Jack Cush reviews the news and updates from the past week on RheumNow.